M&A Deal Summary

Bioventus Acquires Misonix

On July 29, 2021, Bioventus acquired medical products company Misonix for 518M USD

Acquisition Highlights
  • This is Bioventus’ 3rd transaction in the Medical Products sector.
  • This is Bioventus’ largest (disclosed) transaction.
  • This is Bioventus’ 4th transaction in the United States.
  • This is Bioventus’ 1st transaction in New York.

M&A Deal Summary
Date 2021-07-29
Target Misonix
Sector Medical Products
Buyer(s) Bioventus
Deal Type Add-on Acquisition
Deal Value 518M USD
Advisor(s) J.P. Morgan Securities (Financial)
Jones Day (Legal)

Target

Misonix

Farmingdale, New York, United States
Misonix specializes in the development and commercialization of ultrasonic surgical devices for neurosurgical, spinal, advanced wound care, and general surgery procedures. Misonix was founded in 1959 and is based in Farmingdale, New York.

Search 200,500 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Bioventus

Durham, North Carolina, United States
Category Company
Founded 2011
Sector Medical Products
Employees995
Revenue 512M USD (2023)
DESCRIPTION

Bioventus provides clinical and cost-effective therapies and diagnostics to help patients regain active lifestyles. The company's innovative products include bone stimulation devices and osteoarthritis joint fluid therapies. Bioventus was incorporated in 2011 and is based in Durham, North Carolina.

DEAL STATS #
Overall 4 of 5
Sector (Medical Products) 3 of 4
Type (Add-on Acquisition) 3 of 4
State (New York) 1 of 1
Country (United States) 4 of 4
Year (2021) 2 of 2
Size (of disclosed) 1 of 3
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2021-03-30 Bioness

Valencia, California, United States

Bioness is a provider of neuromodulation and rehabilitation medical devices through its innovative peripheral nerve stimulation (“PNS”) therapy and premium rehabilitation solutions. Bioness was founded in 2004 and is based in Valencia, California.

Buy $45M
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2022-04-04 CartiHeal

Kfar-Saba, Israel

CartiHeal is a privately-held medical device company that develops proprietary implants for the treatment of cartilage and osteochondral defects in traumatic and osteoarthritic joints. CartiHeal founded in 2009 and is based in Kfar-Saba, Israel.

Buy $315M
Mergr

Product

Company

Legal